Raltegravir: The First HIV Type 1 Integrase Inhibitor
Raltegravir: The First HIV Type 1 Integrase Inhibitor
About this item
Full title
Author / Creator
Publisher
Oxford: The University of Chicago Press
Journal title
Language
English
Formats
Publication information
Publisher
Oxford: The University of Chicago Press
Subjects
More information
Scope and Contents
Contents
Raltegravir is the first approved human immunodeficiency virus type 1 (HIV-1) integrase inhibitor; it targets the strand transfer step of HIV-1 integration. Clinical trials have demonstrated that raltegravir-containing regimens have potent antiretroviral activity and are well tolerated in HIV-1-infected individuals. In antiretroviral treatment-expe...
Alternative Titles
Full title
Raltegravir: The First HIV Type 1 Integrase Inhibitor
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_755141941
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_755141941
Other Identifiers
ISSN
1058-4838
E-ISSN
1537-6591
DOI
10.1086/597290
